Livedoid Vasculopathy: Clinical Trials

1 trial for Livedoid Vasculopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Livedoid Vasculopathy: new trials by email Literature Review of Livedoid Vasculopathy trials Research Report on Livedoid Vasculopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon
Neovasculgen - Secondary Raynaud's Phenomenon
Phase 1 / Phase 2UnknownArtgen Biotech302015-03-012015-02-05

Narrower conditions

Raynaud Disease (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Peripheral Vascular Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Thrombosis (1)  ·  Vascular Diseases (1)

Sponsors

Artgen Biotech (1)

Countries

Russia (1)